“…In the field of TB research and development, due to an increase in the number of MDR/TDR strains, novel medical strategies focussing on the introduction of new molecules, repurposing and derivatization of present drugs have been developed. In continuation (Rani, Viljoen, Sumanjit, Kremer, & Kumar, ; Shalini, Viljoen, & Kremer, ; Singh, Viljoen, Kremer, & Kumar, , ), the present work describes design and synthesis of a library of hybrids of 1,8‐naphthalimide with three types of hydrazides viz INH, nicotinic hydrazide and pyrazine‐2‐carbohydrazide in order to check their anti‐mycobacterial potency. Our rationale considered two major factors in order to have a potent anti‐TB entity and is based on synergistic effect by two pharmacophoric units: (a) clubbing naphthalimide with a nitrogen heterocycle (hydrazides of nicotinic acid, isonicotinic acid, pyrazinecarboxylic acid) that eventually brings possibility of improving its antibacterial property and (b) protection of NH 2 group of hydrazides by introducing naphthalimide ring so as to evade N ‐acetylation (Figure ).…”